Bioversys Ag (BIOV)

Switzerland
Currency in CHF
34.60
-0.90(-2.54%)
Closed·
BIOV Scorecard
Full Analysis
Suffers from weak gross profit margins
BIOV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
34.4034.70
52 wk Range
33.1037.00
Key Statistics
Edit
Bid/Ask
34.30 / 35.80
Prev. Close
35.5
Open
34.7
Day's Range
34.4-34.7
52 wk Range
33.1-37
Volume
1.12K
Average Volume (3m)
1.54K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
60.00
Upside
+73.41%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a poor free cash flow yield
Show more

Bioversys Ag Company Profile

BioVersys AG, a clinical stage biopharmaceutical company, focuses on identification, development, and commercialization of novel antibacterial products for serious life-threatening infections caused by multi-drug-resistant bacteria. It develops BV100 that is in Phase 3 clinical trial for carbapenem resistant Acinetobacter baumannii lung and blood stream infections; and in Phase 1 trial in patients with hepatic impairment and a bronchoalveolar lavage (BAL). The company is also developing Alpibectir that is in Phase 2a clinical trial for the treatment of pulmonary tuberculosis; BV200 to treat patients with Atopic dermatitis Staphylococcus aureus; and BV500 for non-tuberculous mycobacteria infections. The company was founded in 2008 and is based in Basel, Switzerland.

Compare BIOV to Peers and Sector

Metrics to compare
BIOV
Peers
Sector
Relationship
P/E Ratio
0.0x−0.1x−0.4x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.4x2.6x
Price / LTM Sales
0.0x2.2x2.9x
Upside (Analyst Target)
0.0%216.5%51.7%
Fair Value Upside
Unlock6.1%9.5%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 60.00
(+73.41% Upside)

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Bioversys Ag (BIOV) Stock Price Today?

The Bioversys Ag stock price today is 34.60

What Stock Exchange Does Bioversys Ag Trade On?

Bioversys Ag is listed and trades on the Switzerland Stock Exchange stock exchange.

What Is the Stock Symbol for Bioversys Ag?

The stock symbol for Bioversys Ag is "BIOV."

What Is the Bioversys Ag Market Cap?

As of today, Bioversys Ag market cap is 199.84M.

What Is Bioversys Ag's Earnings Per Share (TTM)?

The Bioversys Ag EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is BIOV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Bioversys Ag Stock Split?

Bioversys Ag has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.